Tetrindole
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
|
|
PubChem CID | |
ChemSpider | |
ChEBI | |
Chemical and physical data | |
Formula | C20H26N2 |
Molar mass | 294.43 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) (verify) |
Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s.[1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.[2]
References[edit]
- ^ Medvedev, AE; Kirkel, AA; Kamyshanskaya, NS; Moskvitina, TA; Axenova, LN; Gorkin, VZ; Andreeva, NI; Golovina, SM; Mashkovsky, MD (20 January 1994). "Monoamine Oxidase Inhibition by Novel Antidepressant Tetrindole". Biochemical Pharmacology. 47 (2): 303–8. doi:10.1016/0006-2952(94)90021-3. PMID 8304974.
- ^ Ramsay, RR; Gravestock, MB (March 2003). "Monoamine Oxidases: to Inhibit or Not to Inhibit". Mini Reviews in Medicinal Chemistry. 3 (2): 129–36. doi:10.2174/1389557033405287. PMID 12570845.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |